Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App





BD Presents Latest Innovations in Patient Safety at Arab Health and MEDLAB Middle East

By LabMedica International staff writers
Posted on 24 Jan 2022

Becton, Dickinson and Company (BD Franklin Lakes, NJ, USA) participated and shared insights with cutting-edge technology solutions enhancing the patient care journey at this year’s Arab Health and MEDLAB 2022 held at the Dubai World Trade Centre. More...

BD presented its latest innovations and solutions focused on patient safety to support clinicians’ efforts to move from piecemeal interventions to a total systems approach for safety at two of the region’s leading medical technology events. At Arab Health 2022, the company demonstrated the full potential of its innovations through the collaboration of its Medical segment with Medication Management Systems and Medication Delivery Systems, and the BD Interventional segment. BD displayed a series of solutions that focused on the prevention of potential medication errors and Healthcare-Associated Infections (HAIs) alongside innovations that empower medical professionals to perform timely, accurate and appropriate diagnostics practices to support effective decision making in providing the safest and most effective care possible in the region.

Additionally, at MEDLAB 2022, the company’s Lifesciences segment showcased integrated diagnostic solutions and services, including safe and integrated specimen collection, specimen diagnosis and data management for better patient comfort. The company also presented solutions that incorporate artificial intelligence to drive laboratory efficiency with customized microbiology automation platforms and dedicated value-added services. Additionally, experts from BD hosted several sessions that addressed the challenges in patient and healthcare worker safety in the post pandemic world. They also highlighted the best practices and demonstrated a variety of services and solutions to help equip healthcare providers in the region with the safe tools leading to better medication management decisions and patient treatment outcomes.

“The pandemic put the healthcare sector to the test in terms of stability and preparedness, demonstrating the need for healthcare providers to adopt advanced technology to meet the growing needs of patients,” said Maher Elhassan, Vice President and General Manager, BD Middle East, North Africa, and Turkey. “Avenues like Arab Health and Medlab give us an invaluable opportunity to raise awareness while facilitating the necessary impetus to our movement of securing and improving the patient care journey for both medical professionals and patients alike. Now more than ever, is the time for organizations and medical institutions to collaborate and achieve greater milestones in patient safety and BD will do everything in its capacity to provide best-in-class MedTech products and services, as we pursue our purpose of advancing the world of health.”

Related Links:
Becton, Dickinson and Company


Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
New
Gold Member
Serum Indices Control
Acusera Serum Indices Control
New
Slide Scanner System
NanoZoomer S540MD
All-in-One Molecular System
AIO M160
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: Dr. Olivia Belbin, head of the Molecular Neurodegeneration Group at IR Sant Pau and study corresponding author, with Alba Cervantes (right), first author and IR Sant Pau researcher (Photo courtesy of IR Sant Pau)

Blood Biomarker Detects Alzheimer’s Changes Decades Before Symptoms in Down Syndrome

Alzheimer’s disease can begin altering the brain long before clinical symptoms appear, creating a challenge for early-stage detection and research. People with Down syndrome face a particularly high age-related... Read more

Molecular Diagnostics

view channel
Photo courtesy of National Human Genome Research Institute

Genomic Screening Expands Detection of Treatable Conditions in Newborns

Conventional newborn screening can miss conditions that lack biochemical biomarkers or present atypically. Initial hearing screens may also fail to detect hearing loss that is later identified through... Read more

Microbiology

view channel
Image: Invasive aspergillosis (IA) is a potentially life-threatening infection caused by Aspergillus mold that primarily affects people with severely weakened immune systems. (Image Credit: Adobe Stock)

Rapid Urine Test Aids Diagnosis of Invasive Aspergillosis

Invasive aspergillosis is an uncommon mold infection in the general population but can pose serious risks for people with weakened immune defenses. Diagnosis can be difficult because existing approaches... Read more

Technology

view channel
Image: The laser-based photoacoustic spectroscopy setup consists of a Mid-IR laser equipped with three QCL modules covering wavelengths from 5.6 μm to 12.9 μm, two silver coated mirrors (SCM), a dichroic mirror (DM) with a transmittance of 90%, a thermal power sensor head (PM) to monitor the output laser power, a mechanical chopper (MC) for frequency modulation and a CEPAS-detector with a self-designed swab holder (SH). (Credit: Graunke, T., Scholz, T., Pieniak, M. et al. Scientific Reports (2026). https://doi.org/10.1038/s41598-026-68298-9)

Laser-Based Swab Analysis Shows Promise for Detecting Disease-Linked Odor Patterns

Disease-related changes in volatile organic compounds can alter body odor, producing measurable patterns in exhaled breath and bodily fluids. Current analytical methods can be complex, time-consuming,... Read more

Industry

view channel
Image: NMPA approvals for Quanterix HD-X and SR-X instruments and four neurology biomarker assays expand access to ultrasensitive blood-based testing in China (Photo courtesy of Quanterix Corporation)

Regulatory Milestone Expands Access to Blood-Based Neurology Biomarker Testing in China

Quanterix Corporation (Billerica, MA, USA) and Innovita Biological Technology Co., Ltd. (Beijing, China) announced regulatory approvals that expand access to Quanterix SIMOA technology and neurology biomarker... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.